These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 1328044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid.
    Sehmi R, Cromwell O, Taylor GW, Kay AB.
    J Immunol; 1991 Oct 01; 147(7):2276-83. PubMed ID: 1655889
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Functional properties of guinea pig eosinophil leukotriene B4 receptor.
    Ng CF, Sun FF, Taylor BM, Wolin MS, Wong PY.
    J Immunol; 1991 Nov 01; 147(9):3096-103. PubMed ID: 1655904
    [Abstract] [Full Text] [Related]

  • 5. Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents.
    Falcone RC, Aharony D.
    J Pharmacol Exp Ther; 1990 Nov 01; 255(2):565-71. PubMed ID: 2173748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT, Froelich LL, Boyd RJ, Schrementi JP, Saussy DL, Schultz RM, Sawyer JS, Sofia MJ, Herron DK, Goodson T, Snyder DW, Pechous PA, Spaethe SM, Roman CR, Fleisch JH.
    J Pharmacol Exp Ther; 1999 Jan 01; 288(1):286-94. PubMed ID: 9862783
    [Abstract] [Full Text] [Related]

  • 8. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ, Pettipher ER, Cheng JB, Breslow R, Conklyn MJ, Farrell CA, Hingorani GP, Salter ED, Hackman BC, Wimberly DJ.
    J Pharmacol Exp Ther; 1995 Apr 01; 273(1):176-84. PubMed ID: 7714764
    [Abstract] [Full Text] [Related]

  • 9. Guinea pig alveolar eosinophils and macrophages produce leukotriene B4 but no peptido-leukotriene.
    Hirata K, Maghni K, Borgeat P, Sirois P.
    J Immunol; 1990 Mar 01; 144(5):1880-5. PubMed ID: 2155267
    [Abstract] [Full Text] [Related]

  • 10. Leukotriene B4 activates the NADPH oxidase in eosinophils by a pertussis toxin-sensitive mechanism that is largely independent of arachidonic acid mobilization.
    Lindsay MA, Perkins RS, Barnes PJ, Giembycz MA.
    J Immunol; 1998 May 01; 160(9):4526-34. PubMed ID: 9574559
    [Abstract] [Full Text] [Related]

  • 11. Biological activity of leukotriene B4 analogs: inhibition of guinea pig eosinophil migration in vitro by the 2,6-disubstituted pyridine analogs U-75,302 and U-75,485.
    Taylor BM, Crittenden NJ, Bruden MN, Wishka DG, Morris J, Richards IM, Sun FF.
    Prostaglandins; 1991 Sep 01; 42(3):211-24. PubMed ID: 1664113
    [Abstract] [Full Text] [Related]

  • 12. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T, Fujii A, Sakai O, Iemura M, Atsumi I, Wada T, Sakaki H.
    Exp Eye Res; 2010 Jul 01; 91(1):85-91. PubMed ID: 20412793
    [Abstract] [Full Text] [Related]

  • 13. Arachidonic acid metabolism in guinea pig eosinophils: synthesis of thromboxane B2 and leukotriene B4 in response to soluble or particulate activators.
    Sun FF, Czuk CI, Taylor BM.
    J Leukoc Biol; 1989 Aug 01; 46(2):152-60. PubMed ID: 2545808
    [Abstract] [Full Text] [Related]

  • 14. Specific binding sites for leukotriene B4 in guinea pig brain membranes.
    de Brum-Fernandes AJ, Guillemette G, Borgeat P, Sirois P.
    J Pharmacol Exp Ther; 1991 Dec 01; 259(3):1035-42. PubMed ID: 1662271
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N, Agrawal DK, Townley RG.
    J Immunol; 1988 Dec 15; 141(12):4291-7. PubMed ID: 2848892
    [Abstract] [Full Text] [Related]

  • 17. [3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site.
    Cheng JB, Cheng EI, Kohi F, Townley RG.
    J Pharmacol Exp Ther; 1986 Jan 15; 236(1):126-32. PubMed ID: 3001280
    [Abstract] [Full Text] [Related]

  • 18. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
    Mencia-Huerta JM, Razin E, Ringel EW, Corey EJ, Hoover D, Austen KF, Lewis RA.
    J Immunol; 1983 Apr 15; 130(4):1885-90. PubMed ID: 6300233
    [Abstract] [Full Text] [Related]

  • 19. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4.
    Goldman DW, Gifford LA, Young RN, Marotti T, Cheung MK, Goetzl EJ.
    J Immunol; 1991 Apr 15; 146(8):2671-7. PubMed ID: 1849936
    [Abstract] [Full Text] [Related]

  • 20. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ, Moqbel R, Cromwell O, Kay AB.
    J Clin Invest; 1986 Dec 15; 78(6):1701-6. PubMed ID: 3023451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.